Nile Therapeutics Rises More Than 3%

Thanks! Share it with your friends!

Close

Nile Therapeutics (NLTX) is up after the company says it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo…

Comments

Write a comment

*

 
Share This Page On:
 
Delicious
powered by: AbhiD.org